Choose date and time: ×
In the last hour
In the last 2 hours
Amgen Inc. Takes Aim at AbbVie Inc. The Motley Fool 12:47
In the last 4 hours
Earlier today
Report Release: Extreme Biotech Meets Extreme Energy Organic Consumers Association 02:18
Ineffective BCG Vaccine Behind TB Cases, Says Expert The New Indian Express 23:01 27-Nov-15
Sieren's China: Test-tube meat Deutsche Welle 15:34 27-Nov-15
Four promising biotech stocks to buy now MoneyWeek 15:15 27-Nov-15
Is it time to take profits in US healthcare? Investment Week 11:32 27-Nov-15
Amarin Co. plc Sees Large Volume Increase (AMRN) Ticker Report 07:48 27-Nov-15
The most popular FierceBiotech stories of 2015 FierceBiotech 07:32 27-Nov-15
Puma Biotechnology Shares Up 4.6% (PBYI) Ticker Report 00:25 27-Nov-15
In the last 7 days
Amarin Co. plc Shares Up 5% (AMRN) Ticker Report 23:55 26-Nov-15
Global Biopharmaceuticals Industry MarketWatch 22:22 26-Nov-15
Amarin Co. plc Sees Strong Trading Volume (AMRN) Ticker Report 20:13 26-Nov-15
The bioeconomy goes global European Biotechnology News 16:39 26-Nov-15
Functional human liver cells grown in the lab Medical Xpress 16:30 26-Nov-15
Moonlighting molecules: finding new uses for old enzymes University of Cambridge 12:45 26-Nov-15
Harsh Goenka-led RPG Group to enter skin care segment The Times of India 11:28 26-Nov-15
Shire prepares new Baxalta bid 10:17 26-Nov-15
Amgen files Humira biosimilar in USA Pharmaceutical Field 09:29 26-Nov-15
Second time around European Biotechnology News 09:17 26-Nov-15
Import of Harvoni to Mongolia postponed 04:24 26-Nov-15
Gilead Sciences Stock Forecast For 2016 Seeking Alpha 02:52 26-Nov-15
Puma Biotechnology Trading 4.6% Higher (PBYI) Ticker Report 01:15 26-Nov-15
Amarin Co. plc Trading 5% Higher (AMRN) Ticker Report 01:15 26-Nov-15

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters
Sorry, no headlines or news topics were found. Please try different keywords.
You’re viewing our new website! — Take a tour